1. MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
    Vanessa Desantis et al, 2020, International Journal of Molecular Sciences CrossRef

  2. LncRNA SLC7A11-AS1 Contributes to Lung Cancer Progression Through Facilitating TRAIP Expression by Inhibiting miR-4775


    Yongmin Liu et al, 2020, OncoTargets and Therapy CrossRef
  3. MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease
    Vanessa Desantis et al, 2021, Cancers CrossRef
  4. NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma
    Chia-Hung Yen et al, 2018, International Journal of Molecular Sciences CrossRef
  5. Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy
    Yin Qianmei et al, 2021, Immunologic Research CrossRef
  6. MicroRNAs and Stem-like Properties: The Complex Regulation Underlying Stemness Maintenance and Cancer Development
    Giuseppina Divisato et al, 2021, Biomolecules CrossRef
  7. A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
    Aristea-Maria Papanota et al, 2021, Cancers CrossRef
  8. The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
    Paweł Robak et al, 2020, Cancers CrossRef